In Conversation With Scientist and CRISPR Pioneer Jennifer Doudna
Posted by btwatson on January 27, 2018 10:07 pm
Tags:
Categories:
Crispr
In Conversation With Scientist and CRISPR Pioneer Jennifer Doudna
Join Susan MacTavish Best in discussion with Jennifer Doudna. You’ll hear about gene editing and how the technology surrounding it has evolved.
Crispr News
-
Intellia Therapeutics: A Leader in CRISPR/Cas9 Genome Editing ... - Best StocksApril 2, 2023
-
CRISPR Therapeutics AG (NASDAQ:CRSP) CEO Samarth Kulkarni ... - MarketBeatApril 1, 2023
-
Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics - The Motley FoolApril 1, 2023
-
Pediatric Cancer Cell Atlas Uncovers Clues About Cancer Drivers ... - GenomeWebMarch 31, 2023
-
Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce ... - Cancer DiscoveryMarch 31, 2023
-
Scribe Therapeutics to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days - Yahoo FinanceMarch 31, 2023
-
This Top Growth Stock Is Targeting a Multi-Billion-Dollar Market ... - NasdaqMarch 31, 2023
-
Genome-wide tiled detection of circulating Mycobacterium ... - Nature.comMarch 31, 2023
-
5 Bargain-Basement Stocks to Buy Right Now - NasdaqMarch 31, 2023
-
Buy Crispr Therapeutics On Approval Odds (NASDAQ:CRSP) - Seeking AlphaMarch 31, 2023
-
Opportunity in the CRISPR Gene Editing Market | High Market ... - MedgadgetMarch 31, 2023
-
CRISPR cats and dogs? Royal Society for the Prevention of Cruelty ... - Genetic Literacy ProjectMarch 31, 2023
-
CRISPR pioneer Jennifer Doudna to speak April 4 in Chicago - Northwestern NowMarch 31, 2023
-
Brassinosteroid gene regulatory networks at cellular resolution in ... - ScienceMarch 30, 2023
-
CRISPR editing in the lung with novel lipids - Nature.comMarch 30, 2023
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.